UB Paderborn / Katalog / Suche / in CDI

Trastuzumab duocarmazine in locally advanced and metastatic solid tumours and HER2-expressing breast cancer: a phase 1 dose-escalation and dose-expansion study

The lancet oncology, 2019-08, Vol.20 (8), p.1124-1135

2019

Volltextzugriff (PDF)

Recent strategies targeting HIV glycans in vaccine design

Nature chemical biology, 2014-12, Vol.10 (12), p.990

2014

Volltextzugriff (PDF)

Eribulin, Child-Pugh score, and liver-function tests: lessons from pivotal breast cancer studies 301 and 305

Breast cancer research : BCR, 2021-03, Vol.23 (1), p.33-9, Article 33

2021

Volltextzugriff (PDF)

Genomic profile of advanced breast cancer in circulating tumour DNA

Nature communications, 2021-04, Vol.12 (1), p.2423-12, Article 2423

2021

Volltextzugriff (PDF)

The impact of medication side effects on adherence and persistence to hormone therapy in breast cancer survivors: A qualitative systematic review and thematic synthesis

Breast (Edinburgh), 2021-08, Vol.58, p.147-159

2021

Volltextzugriff (PDF)

Mutant p53s generate pro-invasive niches by influencing exosome podocalyxin levels

Nature communications, 2018-11, Vol.9 (1), p.5069-17, Article 5069

2018

Volltextzugriff (PDF)

Glutaminolysis drives membrane trafficking to promote invasiveness of breast cancer cells

Nature communications, 2017-12, Vol.8 (1), p.2255-2255, Article 2255

2017

Volltextzugriff (PDF)

PINK1 drives production of mtDNA-containing extracellular vesicles to promote invasiveness

The Journal of cell biology, 2021-12, Vol.220 (12), p.1

2021

Volltextzugriff (PDF)

Secreted CLIC3 drives cancer progression through its glutathione-dependent oxidoreductase activity

Nature communications, 2017-02, Vol.8 (1), p.14206-14206, Article 14206

2017

Volltextzugriff (PDF)

The impact of symptom clusters on endocrine therapy adherence in patients with breast cancer

Breast (Edinburgh), 2024-06, Vol.75, p.103731-103731, Article 103731

2024

Volltextzugriff (PDF)

Comparing Breast Cancer Multiparameter Tests in the OPTIMA Prelim Trial: No Test Is More Equal Than the Others

JNCI : Journal of the National Cancer Institute, 2016-09, Vol.108 (9), p.djw050

2016

Volltextzugriff (PDF)

A phase I/II study of epertinib plus trastuzumab with or without chemotherapy in patients with HER2-positive metastatic breast cancer

Breast cancer research : BCR, 2019-12, Vol.22 (1), p.1-9, Article 1

2019

Volltextzugriff (PDF)

CLIC3 controls recycling of late endosomal MT1-MMP and dictates invasion and metastasis in breast cancer

Journal of cell science, 2014-09, Vol.127 (Pt 18), p.3893-3901

2014

Volltextzugriff (PDF)

The impact of medication side effects on adherence and persistence to hormone therapy in breast cancer survivors: A quantitative systematic review

Breast (Edinburgh), 2022-08, Vol.64, p.63-84

2022

Volltextzugriff (PDF)

A real-world study of the first use of palbociclib for the treatment of advanced breast cancer within the UK National Health Service as part of the novel Ibrance® Patient Program

British journal of cancer, 2023-09, Vol.129 (5), p.852-860

2023

Volltextzugriff (PDF)

A randomised controlled trial of interventions for taxane-induced nail toxicity in women with early breast cancer

Scientific reports, 2022-07, Vol.12 (1), p.11575-11575, Article 11575

2022

Volltextzugriff (PDF)

High Temperature SELMA: Evolution of DNA-Supported Oligomannose Clusters Which Are Tightly Recognized by HIV bnAb 2G12

Journal of the American Chemical Society, 2014-02, Vol.136 (5), p.1726-1729

2014

Volltextzugriff (PDF)

Rab25 and CLIC3 Collaborate to Promote Integrin Recycling from Late Endosomes/Lysosomes and Drive Cancer Progression

Developmental cell, 2012-01, Vol.22 (1), p.131-145

2012

Volltextzugriff (PDF)

Phase I Dose-Escalation and Pharmacokinetic Study of Dasatinib in Patients with Advanced Solid Tumors

Clinical cancer research, 2009-10, Vol.15 (19), p.6232-6240

2009

Volltextzugriff (PDF)

Cellular Uptake of Tile-Assembled DNA Nanotubes

Nanomaterials (Basel, Switzerland), 2014-12, Vol.5 (1), p.47-60

2014

Volltextzugriff (PDF)

Olaparib and Ceralasertib (AZD6738) in Patients with Triple-Negative Advanced Breast Cancer: Results from Cohort E of the plasmaMATCH Trial (CRUK/15/010)

Clinical cancer research, 2023-12, Vol.29 (23), p.4751

2023

Volltextzugriff (PDF)

Stochastic Pharmacokinetic-Pharmacodynamic Modeling for Assessing the Systemic Health Risk of Perfluorooctanoate (PFOA)

Toxicological sciences, 2018-05, Vol.163 (1), p.293-306

2018

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Trastuzumab duocarmazine in locally advanced and metastatic solid tumours and HER2-expressing breast cancer: a phase 1 dose-escalation and dose-expansion study

Recent strategies targeting HIV glycans in vaccine design

Circulating tumour DNA analysis to direct therapy in advanced breast cancer (plasmaMATCH): a multicentre, multicohort, phase 2a, platform trial

Eribulin, Child-Pugh score, and liver-function tests: lessons from pivotal breast cancer studies 301 and 305

Genomic profile of advanced breast cancer in circulating tumour DNA

The impact of medication side effects on adherence and persistence to hormone therapy in breast cancer survivors: A qualitative systematic review and thematic synthesis

Mutant p53s generate pro-invasive niches by influencing exosome podocalyxin levels

Niraparib for Advanced Breast Cancer with Germline BRCA1 and BRCA2 Mutations: the EORTC 1307-BCG/BIG5-13/TESARO PR-30-50-10-C BRAVO Study

Glutaminolysis drives membrane trafficking to promote invasiveness of breast cancer cells

PINK1 drives production of mtDNA-containing extracellular vesicles to promote invasiveness

Secreted CLIC3 drives cancer progression through its glutathione-dependent oxidoreductase activity

The impact of symptom clusters on endocrine therapy adherence in patients with breast cancer

Comparing Breast Cancer Multiparameter Tests in the OPTIMA Prelim Trial: No Test Is More Equal Than the Others

A phase I/II study of epertinib plus trastuzumab with or without chemotherapy in patients with HER2-positive metastatic breast cancer

CLIC3 controls recycling of late endosomal MT1-MMP and dictates invasion and metastasis in breast cancer

The impact of medication side effects on adherence and persistence to hormone therapy in breast cancer survivors: A quantitative systematic review

A real-world study of the first use of palbociclib for the treatment of advanced breast cancer within the UK National Health Service as part of the novel Ibrance® Patient Program

A randomised controlled trial of interventions for taxane-induced nail toxicity in women with early breast cancer

High Temperature SELMA: Evolution of DNA-Supported Oligomannose Clusters Which Are Tightly Recognized by HIV bnAb 2G12

Rab25 and CLIC3 Collaborate to Promote Integrin Recycling from Late Endosomes/Lysosomes and Drive Cancer Progression

Phase I Dose-Escalation and Pharmacokinetic Study of Dasatinib in Patients with Advanced Solid Tumors

Cellular Uptake of Tile-Assembled DNA Nanotubes

Olaparib and Ceralasertib (AZD6738) in Patients with Triple-Negative Advanced Breast Cancer: Results from Cohort E of the plasmaMATCH Trial (CRUK/15/010)

Stochastic Pharmacokinetic-Pharmacodynamic Modeling for Assessing the Systemic Health Risk of Perfluorooctanoate (PFOA)

Triplet Therapy with Palbociclib, Taselisib, and Fulvestrant in PIK3CA -Mutant Breast Cancer and Doublet Palbociclib and Taselisib in Pathway-Mutant Solid Cancers

Suchergebnisse filtern